跳至主要内容
临床试验/NL-OMON43354
NL-OMON43354
已完成
不适用

An international field study for the reliability and validity of the EORTC Sexual Health Questionnaire (EORTC SHQ-C22) for assessing sexual health in cancer patients. - EORTC Sexual Health Questionnaire

Medical University Graz0 个研究点目标入组 40 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
Medical University Graz
入组人数
40
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Observational non invasive

研究者

发起方
Medical University Graz

入排标准

入选标准

  • The study sample will be composed of a consecutive series of cancer patients who meet the study eligibility criteria in each participating centre. Study participants will be enrolled in four groups: Group A: Patients undergoing surgery alone Group B: Patients who receive chemotherapy and/or radiotherapy and/or endocrine therapies as first line treatment with curative intention Group C: Patients who receive palliative treatment (any treatment) Group D: Patients with no evidence of disease who have completed treatment for at least 6 months up to 5 years (test\-retest) The SHQ\-C22 will be used in patients from across all cancer sites and stages. Sampling will be on the basis of gender, age, primary cancer diagnosis and treatment. a) Histological confirmed diagnosis of cancer (primary, recurrent or metastatic disease) b) Any tumour site and stage c) Mentally fit to complete the questionnaires d) Able to understand the language of the questionnaires e) 18 years of age or above f) Patient is willing to give informed written consent

排除标准

  • Patients participating in other QoL studies that might interfere with this study b) Patients who are unable to self\-complete the questionnaires

结局指标

主要结局

未指定

相似试验